TY - JOUR AU - Sultana, A. AU - Tudur Smith, C. AU - Cunningham, D. AU - Starling, N. AU - Neoptolemos, J. AU - Ghaneh, P. PY - 2007 DA - 2007// TI - Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2551 DO - 10.1200/JCO.2006.09.2551 ID - Sultana2007 ER - TY - JOUR AU - Boeck, S. AU - Hoehler, T. AU - Seipelt, G. AU - Mahlberg, R. AU - Wein, A. AU - Hochhaus, A. AU - Boeck, H. AU - Schmid, B. AU - Kettner, E. AU - Stauch, M. AU - Lordick, F. AU - Ko, Y. AU - Geissler, M. AU - Schoppmeyer, K. AU - Kojouharoff, G. AU - Golf, A. AU - Neugebauer, S. AU - Heinemann, V. PY - 2008 DA - 2008// TI - Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicentre randomised phase II trial in advanced pancreatic cancer JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdm467 DO - 10.1093/annonc/mdm467 ID - Boeck2008 ER - TY - JOUR AU - Song, F. AU - Glenny, A. -. M. AU - Altman, D. PY - 2000 DA - 2000// TI - Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery JO - Control Clin Trials VL - 21 UR - https://doi.org/10.1016/S0197-2456(00)00055-6 DO - 10.1016/S0197-2456(00)00055-6 ID - Song2000 ER - TY - JOUR AU - Bucher, H. AU - Guyatt, G. AU - Griffith, L. AU - Walter, S. PY - 1997 DA - 1997// TI - The results of direct and indirect treatment comparisons in meta-analysis of randomised controlled trials JO - J Clin Epidemiol VL - 50 UR - https://doi.org/10.1016/S0895-4356(97)00049-8 DO - 10.1016/S0895-4356(97)00049-8 ID - Bucher1997 ER - TY - JOUR AU - Parmar, M. AU - Torri, V. AU - Stewart, L. PY - 1998 DA - 1998// TI - Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints JO - Statistics in Medicine VL - 17 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Parmar1998 ER - TY - JOUR AU - Song, F. AU - Altman, D. AU - Glenny, A. -. N. AU - Deeks, J. PY - 2003 DA - 2003// TI - Validity of indirect comparison for estimating efficacy of competing interventions: emperical evidence from published meta-analyses JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7387.472 DO - 10.1136/bmj.326.7387.472 ID - Song2003 ER - TY - JOUR AU - Smith, D. B. AU - Neoptolemos, J. P. PY - 2006 DA - 2006// TI - Capecitabine in carcinoma of the pancreas JO - Expert Opin Pharmacother VL - 7 UR - https://doi.org/10.1517/14656566.7.12.1633 DO - 10.1517/14656566.7.12.1633 ID - Smith2006 ER - TY - JOUR AU - Berlin, J. D. AU - Catalano, P. AU - Thomas, J. P. AU - Kugler, J. W. AU - Haller, D. G. AU - Benson, A. B. PY - 2002 DA - 2002// TI - Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297 JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.11.149 DO - 10.1200/JCO.2002.11.149 ID - Berlin2002 ER - TY - CHAP AU - Reiss, H. AU - Helm, A. AU - Niedergethmann, M. AU - Schmidt-Wolf, I. AU - Moik, M. AU - Hammer, C. AU - Zippel, K. AU - Weigang-Kohler, K. AU - Stauch, M. AU - Oettle, H. PY - 2005 DA - 2005// TI - A randomised, prospective, multicentre, phase III trial of gemcitabine, 5-Fluorouracil, folinic acid versus gemcitabine alone in patients with advanced pancreatic cancer BT - ASCO Annual Meeting: 2005 ID - Reiss2005 ER - TY - JOUR AU - Di Costanzo, F. AU - Carlini, P. AU - Doni, L. AU - Massidda, B. AU - Mattioli, R. AU - Iop, A. AU - Barletta, E. AU - Moscetti, L. AU - Recchia, F. AU - Tralongo, P. AU - Gasperoni, S. PY - 2005 DA - 2005// TI - Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC) JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602640 DO - 10.1038/sj.bjc.6602640 ID - Di Costanzo2005 ER - TY - CHAP PY - 2007 DA - 2007// BT - TeloVac: A prospective, phase III, controlled, multicentre, randomised clinical trial comparing combination Gemcitabine and Capecitabine therapy with concurrent and sequential chemoimmunotherapy using a telomerase vaccine in locally advanced and metastatic pancreatic cancer ID - ref11 ER - TY - CHAP AU - Cunningham, D. AU - Chau, I. AU - Stocken, D. AU - Davies, C. AU - Dunn, J. AU - Valle, J. AU - Smith, D. AU - Steward, W. AU - Harper, P. AU - Neoptolemos, J. PY - 2005 DA - 2005// TI - Phase III randomised comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer BT - Eur J Can ID - Cunningham2005 ER - TY - CHAP AU - Hermann, R. AU - Bodoky, G. AU - Ruhstaller, T. AU - Glimelius, B. AU - Saletti, P. AU - Bajetta, E. AU - Schueller, J. AU - Bernhard, J. AU - Dietrich, D. AU - Scheithauer, W. PY - 2005 DA - 2005// TI - Gemcitabine plus capecitabine versus gemcitabine alone in locally advanced or metastatic pancreatic cancer. A randomised phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG) BT - 2005 ASCO Annual Meeting: 2005; Orlando, USA ID - Hermann2005 ER - TY - JOUR AU - Herrmann, R. AU - Bodoky, G. AU - Ruhstaller, T. AU - Glimelius, B. AU - Bajetta, E. AU - Schueller, J. AU - Saletti, P. AU - Bauer, J. AU - Figer, A. AU - Pestalozzi, B. AU - Kohne, C. AU - Mingrone, W. AU - Stemmer, S. AU - Tamas, K. AU - Kornek, G. V. AU - Koeberle, D. AU - Cina, S. AU - Bernhard, J. AU - Dietrich, D. AU - Scheithauer, W. PY - 2007 DA - 2007// TI - Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomised, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.0886 DO - 10.1200/JCO.2006.09.0886 ID - Herrmann2007 ER - TY - JOUR AU - Scheithauer, W. AU - Schull, B. AU - Ulrich-Pur, H. AU - Schmid, K. AU - Raderer, M. AU - Haider, K. AU - Kwasny, W. AU - Depisch, D. AU - Schneeweiss, B. AU - Lang, F. AU - Kornek, G. V. PY - 2003 DA - 2003// TI - Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastastic pancreatic adenocarcinoma: a randomised phase II trial JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg029 DO - 10.1093/annonc/mdg029 ID - Scheithauer2003 ER - TY - JOUR AU - Heinemann, V. AU - Quietzsch, D. AU - Gieseler, F. AU - Gonnermann, M. AU - Schonekas, H. AU - Rost, A. AU - Neuhaus, H. AU - Haag, C. AU - Clemens, M. AU - Heinrich, B. AU - Vehling-Kaiser, U. AU - Fuchs, M. AU - Fleckenstein, D. AU - Geisierich, W. AU - Uthgennant, D. AU - Einsele, H. AU - Holstege, A. AU - Hinke, A. AU - Schalhorn, A. AU - Wilkowski, R. PY - 2006 DA - 2006// TI - Randomised phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.05.1490 DO - 10.1200/JCO.2005.05.1490 ID - Heinemann2006 ER - TY - JOUR AU - Louvet, C. AU - Labianca, R. AU - Hammel, P. AU - Lledo, G. AU - Zampino, M. AU - Andre, T. AU - Zaniboni, A. AU - Ducreux, M. AU - Aitini, E. AU - Taieb, J. AU - Faroux, R. AU - Lepere, C. AU - de Gramont, A. PY - 2005 DA - 2005// TI - Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.06.023 DO - 10.1200/JCO.2005.06.023 ID - Louvet2005 ER - TY - BOOK AU - Poplin, E. AU - Levy, D. AU - Berlin, J. AU - Rothenberg, M. AU - Cella, D. AU - Mitchell, E. AU - Alberts, S. AU - Benson, A. PY - 2006 DA - 2006// TI - Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-dose rate infusion) versus gemcitabine + oxaliplatin in patients with advanced pancreatic cancer (E6201) ID - Poplin2006 ER - TY - JOUR AU - Rocha Lima, C. AU - Green, M. AU - Rotche, R. AU - Miller, W. AU - Jeffrey, G. AU - Cisar, L. AU - Morganti, A. AU - Orlando, N. AU - Gruia, G. AU - Miller, L. PY - 2004 DA - 2004// TI - Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.12.082 DO - 10.1200/JCO.2004.12.082 ID - Rocha Lima2004 ER - TY - CHAP AU - Stathopoulos, G. AU - Aravantinos, G. AU - Syrigos, K. AU - Kalbakis, K. AU - Karvounis, N. AU - Papakotoulas, P. AU - Boukovinas, J. AU - Potamianou, A. AU - Polyzos, A. AU - Christophillakis, C. AU - Georgoulias, V. PY - 2005 DA - 2005// TI - A randomised phase III study of irinotecan/gemcitabine combination versus gemcitabine in patients with advanced/metastatic pancreatic cancer BT - 2005 ASCO Annual Meeting: 2005; Orlando, USA ID - Stathopoulos2005 ER - TY - JOUR AU - Stathopoulos, G. AU - Syrigos, K. AU - Aravantinos, G. AU - Polyzos, A. AU - Papakotoulas, P. AU - Fountzilas, P. AU - Potamianou, A. AU - Ziras, N. AU - Boukovinas, J. AU - Varthalitis, J. AU - Androulakis, N. AU - Kotsakis, A. AU - Samonis, G. AU - Georgoulias, V. PY - 2006 DA - 2006// TI - A multicentre phase III trial comparing irinotecan-gemcitabine with gemcitabine monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer JO - Br J Cancer VL - 95 UR - https://doi.org/10.1038/sj.bjc.6603301 DO - 10.1038/sj.bjc.6603301 ID - Stathopoulos2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/8/192/prepub UR - http://www.biomedcentral.com/1471-2407/8/192/prepub ID - ref22 ER -